AMZ2 antibody

Este producto es parte de AMZ - Archaelysin family metallopeptidase
Product Graph
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
AMZ2 antibody
category
Primary Antibodies
provider
FineTest
reference
FNab00386
tested applications
ELISA, WB, IHC

Description

Zinc metalloprotease. Exhibits activity against angiotensin-3 in vitro. Does not hydrolyze either neurogranin or angiotensin-2.

Documents del producto

Instrucciones
Descargar
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
archaelysin family metallopeptidase 2 (AMZ2)
Host
Rabbit
Reactivity
Human, Mouse, Rat
Recommended Dilution
WB: 1:500-1:5000; IHC: 1:20-1:200; IF: 1:20-1:200
Clonality
polyclonal
Conjugation
Unconjugated
Isotype
IgG
Observed MW
41 kDa
Purity
≥95% as determined by SDS-PAGE
Purification
Immunogen affinity purified
Size 1
100µg
Form
liquid
Tested Applications
ELISA, WB, IHC
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
UniProt ID
Q86W34
Gene ID
51321
Alias
AMZ2
Background
Antibody anti-AMZ2
Status
RUO
Note
Mol. Weight 41 kDa

Descripción

AMZ2, like AMZ1, is a zinc-dependent metallopeptidase that functions in the regulation of protein degradation and extracellular matrix remodeling. AMZ2 is widely expressed in tissues, including those involved in immune responses and connective tissue maintenance. AMZ2 has been shown to play a role in proteolytic processes that modulate cellular signaling pathways, tissue repair, and organ development. Its enzymatic activity depends on zinc ions, which are essential for stabilizing the active site and facilitating substrate cleavage. AMZ2 is involved in regulating inflammatory processes by processing bioactive peptides and matrix proteins, contributing to tissue remodeling during immune responses and injury repair. Dysregulation of AMZ2 has been associated with chronic inflammation, cancer progression, and neurodegenerative diseases, where altered proteolytic activity can disrupt tissue integrity and cellular signaling. AMZ2 is emerging as a potential target for therapeutic interventions aimed at modulating protease activity in pathological conditions.

Related Products

FNab00386

AMZ2 antibody

Zinc metalloprotease. Exhibits activity against angiotensin-3 in vitro. Does not hydrolyze either neurogranin or angiotensin-2.

Ver Producto
abx111040

Archaelysin Family Metallopeptidase 2 (AMZ2) Antibody

Archaelysin Family Metallopeptidase 2 Antibody is a Rabbit Polyclonal antibody against Archaelysin Family Metallopeptidase 2.

Ver Producto
abx230386

Archaelysin Family Metallopeptidase 2 (AMZ2) Antibody

AMZ2 Antibody is a Rabbit Polyclonal against AMZ2.

Ver Producto